SOPHiA GENETICS SA SALES AGREEMENTSales Agreement • August 8th, 2023 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 8th, 2023 Company Industry JurisdictionSOPHiA GENETICS SA, a corporation (société anonyme) incorporated under the laws of Switzerland (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
COMMON STOCK SALES AGREEMENTSales Agreement • November 8th, 2022 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 8th, 2022 Company Industry Jurisdiction
ORPHAZYME A/S AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE SALES AGREEMENTSales Agreement • November 4th, 2021 • Orphazyme a/S • Pharmaceutical preparations • New York
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionOrphazyme A/S, a public limited liability company (Aktieselskab) organized and existing under the laws of the Kingdom of Denmark (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
TRICIDA, INC. COMMON STOCK SALES AGREEMENTSales Agreement • January 22nd, 2021 • Tricida, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2021 Company Industry JurisdictionTricida, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
OYSTER POINT PHARMA, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 5th, 2020 • Oyster Point Pharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 5th, 2020 Company Industry JurisdictionOyster Point Pharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
ADURO BIOTECH, INC. cOMMON STOCK SALES AGREEMENTSales Agreement • August 2nd, 2017 • Aduro Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 2nd, 2017 Company Industry Jurisdiction
TURNING POINT BRANDS, INC. $50,000,000 COMMON STOCK FORM OF SALES AGREEMENTSales Agreement • June 30th, 2017 • Turning Point Brands, Inc. • Tobacco products • New York
Contract Type FiledJune 30th, 2017 Company Industry JurisdictionTurning Point Brands, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
OXFORD IMMUNOTEC GLOBAL PLC $40,000,000 ORDINARY SHARES SALES AGREEMENTSales Agreement • December 21st, 2016 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
Contract Type FiledDecember 21st, 2016 Company Industry JurisdictionOxford Immunotec Global PLC (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
AMICUS THERAPEUTICS, INC. $100,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENTSales Agreement • February 26th, 2016 • Amicus Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 26th, 2016 Company Industry JurisdictionAmicus Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
COMMON STOCK SALES AGREEMENTSales Agreement • December 23rd, 2013 • Endocyte Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 23rd, 2013 Company Industry Jurisdiction
RAPTOR PHARMACEUTICAL CORP. SALES AGREEMENTSales Agreement • May 1st, 2012 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 1st, 2012 Company Industry JurisdictionRaptor Pharmaceutical Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: